X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

EXPERIMENTAL AND MOLECULAR MEDICINE

期刊標題檢索 EXP MOL MED 最新評論: It has been over 2 months since I submitted my paper, invited 7 revie... (2024-08-21)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[EXPERIMENTAL AND MOLECULAR MEDICINE]您好,您是該頁面的第 89821 位訪客。

期刊簡介
期刊名稱EXPERIMENTAL AND MOLECULAR MEDICINE EXPERIMENTAL AND MOLECULAR MEDICINE
LetPub Score
7.2
50 ratings
Rate

Reputation
8.1

Influence
6.4

Speed
6.9

期刊簡稱EXP MOL MED
ISSN1226-3613
E-ISSN2092-6413
h-index68
CiteScore
CiteScoreSJRSNIPCiteScore Rank
19.503.6712.329
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Clinical Biochemistry
Q13 / 117
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Biochemistry
Q116 / 438
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q18 / 178
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q123 / 410

自引率 (2023-2024)2.10%自引率趨勢
掲載範囲
Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal.

Topics of particular interest within the journal's scope include, but are not limited to, those listed below:

Cancer biology
Immunology
Neuroscience
Cardiovascular biology
Genetics and genomics
Gene therapy
Metabolic diseases
Stem cells and regenerative medicine
Physiology and diseases
Molecular Medicine.
官方網站https://www.nature.com/emm
在線稿件提交https://mts-emm.nature.com/
開放訪問Yes
出版商Springer Nature
主題領域医学
出版國/地區SOUTH KOREA
發行頻率四半期刊行
創刊年1999
每年文章數208每年文章數趨勢
黃金OA百分比99.82%
OA Related Info
APC: Yes( GBP3190; USD4490; EUR3790; )
APC waiver:Check Notes
Other charges: No
Keywords: cancer biology、cardiovascular biology、metabolic diseases、molecular medicine、stem cells、regenerative medicine
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ122/313
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ113/189
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1226-3613%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 3 Month(s)
競爭力 *來自作者的數據: About 65%
參考鏈接
相關期刊 【EXPERIMENTAL AND MOLECULAR MEDICINE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1336471
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS575469
    JOURNAL OF BIOLOGICAL CHEMISTRY396211
    NUCLEIC ACIDS RESEARCH343168
    CELL298611
    FASEB JOURNAL271279
    International Journal of Biological Sciences241604
    Molecular Cancer229998
    PLANT SCIENCE228338
    ONCOGENE203922
  •  

    EXPERIMENTAL AND MOLECULAR MEDICINE EXPERIMENTAL AND MOLECULAR MEDICINE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/11)
  [EXPERIMENTAL AND MOLECULAR MEDICINE] 的評論撰寫評論
作者: llxxqq


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 11:19:59 評論於
It has been over 2 months since I submitted my paper, invited 7 reviewers, but only one has agreed so far. The review process seems endless and I regret not having a good strategy before submitting. Now I am anxious every day.
(0) 讚! | llxxqq

作者: sunshineZY


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-23 18:16:17 評論於
Your comment is the most valuable reference in all the comment sections. Liked, appreciated, eager to graduate, and considering investing in it, I researched it and indeed the pattern you mentioned is the same! I decisively gave up
(0) 讚! | sunshineZY

作者: 终幕亦瑶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-20 10:35:43 評論於
After making the decision, how is the situation with your article? Thank you
(0) 讚! | 终幕亦瑶

作者: Murphy Roy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-28 20:18:01 評論於
Review speed: 6.0
Emphasis on research direction: Heart development
Experience sharing: Slow! It's been over 5 months since submission! Still under review!
(0) 讚! | Murphy Roy

作者: 木木


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-19 21:30:53 評論於
How did your final draft turn out? Did you work with an editor?
(0) 讚! | 木木

作者: 八卦寻芹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-02 22:47:13 評論於
Has there been any movement on your article? I submitted mine in November 2023 and it is still under review
(0) 讚! | 八卦寻芹

作者: 千花凌兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-29 08:17:16 評論於
How long did it take to receive revisions after receiving reviewer feedback on the system?
(0) 讚! | 千花凌兰

作者: 五虎海菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-25 08:16:25 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0 Research focus: Single-cell sequencing Experience sharing: None
(0) 讚! | 五虎海菡

作者: 长安海青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-17 22:24:02 評論於
Not rejected after submission, right? That's the same for me. A few hours after submission, it already shows "under review." It doesn't seem like it was sent for external review that quickly
(0) 讚! | 长安海青

作者: 长安海青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-17 09:19:33 評論於
I am the same way, it shows "under review" every few hours, but I don't think it means it's being sent for external review
(0) 讚! | 长安海青

作者: Murphy Roy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 18:31:01 評論於
The first instance result should be replied in 2-3 months!
(0) 讚! | Murphy Roy

作者: 碧水秋芳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-04 17:16:05 評論於
Submission success rate: 25.0
Experience sharing: I wrote a letter to the editorial department, and they responded that the editorial decision would take 2-3 months. Is this serious? Thank you for your asking. Currently, the paper EMM is under review. I'm sorry I couldn't tell you in detail, and I ask for your understanding. The paper is in the process of the editor checking the paper, and we inform you that it will take about 2-3 months from submission to the first decision letter. Thank you. Sincerely yours, Heehyun Park
(0) 讚! | 碧水秋芳

作者: 重阳绮思


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-22 15:44:27 評論於
I received an email stating it was incomplete, so I checked multiple times and couldn't find anything unfinished. I really don't understand
(0) 讚! | 重阳绮思

作者: 孤云白枫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-20 13:00:53 評論於
It has been almost a month since submission, and the journal system still shows "under review." Research Square shows Editor assigned on October 25, 2023, and submission checks complete on October 30, 2023... This submission is UNDER CONSIDERATION at Experimental & Molecular Medicine. Just have to wait
(0) 讚! | 孤云白枫

作者: 重阳绮思


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-14 21:12:59 評論於
What's next? Is the review time long?
(0) 讚! | 重阳绮思

作者: 重阳绮思


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-14 20:26:49 評論於
Does this mean it has been submitted for review?
(0) 讚! | 重阳绮思

作者: 重阳绮思


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-14 08:05:15 評論於
What's the reason for this? Is the submission not completed?
(0) 讚! | 重阳绮思

作者: 不灭昌翰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-02 19:49:14 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0 Experience sharing: Review speed is too slow
(0) 讚! | 不灭昌翰

作者: 晨风泽睿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-30 10:14:53 評論於
Just saying that the content cannot be viewed, nothing else ?
(0) 讚! | 晨风泽睿

作者: 蓉沼闲静


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-27 22:01:26 評論於
Review speed: 3.0 Experience sharing: May I ask senior students whether the meaning of this is that the content of the article does not comply with the requirements of the journal and should be rejected
(0) 讚! | 蓉沼闲静

作者: 不灭昌翰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-08 12:45:00 評論於
How are you doing now?
(0) 讚! | 不灭昌翰

作者: 上清元洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-21 14:24:24 評論於
On the 27th day, got rejected and was recommended 11 journals under Nature
(0) 讚! | 上清元洲

作者: wq.


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-18 15:26:48 評論於
How is your follow-up going? When will you give your advice, and how long is the cycle?
(0) 讚! | wq.

作者: 上清元洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-11 10:06:55 評論於
It's been 20 days for me too. Still no update on Current Stage
(0) 讚! | 上清元洲

作者: 是浩然吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-10 13:28:08 評論於
What about the rest?
(0) 讚! | 是浩然吖

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/11)

開始撰寫 [EXPERIMENTAL AND MOLECULAR MEDICINE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*